FIELD: medicine.
SUBSTANCE: oligoadenylate synthetase 1 protein shows antiviral activity and consists of an amino acid sequence SEQ ID NO:1 wherein methionine in position 1 is removed, while the amino acid in position 162 is glycine.
EFFECT: higher clinical effectiveness in a viral disease.
8 cl, 18 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MULTIMERIZING POLYPEPTIDES DERIVED FROM DOMAIN WITH ROLL-TYPE PENTONE BASE OF ADENOVIRUS | 2019 |
|
RU2820522C2 |
| SELF-ASSEMBLED NANOSTRUCTURED VACCINES | 2019 |
|
RU2811439C2 |
| IMMUNOCYTOKINES BASED ON IL-15 AND IL-15Rα OF THE SUSHI DOMAIN | 2012 |
|
RU2763298C2 |
| CD123-SPECIFIC CHIMERIC ANTIGENIC RECEPTORS FOR CANCER IMMUNOTHERAPY | 2015 |
|
RU2727290C2 |
| MULTIVALENT PD-L1-BINDING COMPOUNDS FOR TREATING MALIGNANT NEOPLASMS | 2020 |
|
RU2816646C2 |
| STRUCTURES HAVING SIRP-ALPHA DOMAIN OR ITS VERSION | 2016 |
|
RU2740672C2 |
| NEW FISH CORONAVIRUS | 2020 |
|
RU2813731C2 |
| LUCIFERIN BIOSYNTHESIS ENZYMES AND USE THEREOF | 2018 |
|
RU2730038C2 |
| CAFFEYLPYRUVATE HYDROLASES AND THEIR USE | 2020 |
|
RU2812474C2 |
| COMPOSITIONS CONTAINING CURONES AND WAYS OF APPLICATION THEREOF | 2018 |
|
RU2822800C2 |
